SCHEMBL26512485

SCHEMBL26512485

NC1=NNC(=O)/C1=N\Nc1ccccc1F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.34
KDM4E B2RXH2 2/20 0.34
KDM4A O75164 1/20 0.34
GAA P10253 1/20 0.34
KMT2A Q03164 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
RAB9A P51151 4/20 0.33
NPC1 O15118 4/20 0.33
PSIP1 O75475 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 2/20 0.33
HTT P42858 2/20 0.33
C1R P00736 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
LMNA P02545 1/20 0.32
LRRK2 Q5S007 1/20 0.32
CDC25B P30305 1/20 0.31
TNKS2 Q9H2K2 1/20 0.31
AKT1 P31749 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26123852 0.83 KMT2A (0.32) MAPTKDM4EKDM4AGAAKMT2A
SCHEMBL26512512 0.83 KMT2A (0.32) MAPTKDM4EKDM4AGAAKMT2A
SCHEMBL26123853 0.80 KMT2A (0.30) MAPTKDM4EKDM4AGAAKMT2A
SCHEMBL30697307 0.80 KMT2A (0.30) MAPTKDM4EKDM4AGAAKMT2A
SCHEMBL25291704 0.77 RAB9A (0.36) MAPTKDM4EGAAKMT2ARAB9A
SCHEMBL26512482 0.77 NPC1 (0.40) MAPTKDM4EKDM4AGAAKMT2A
SCHEMBL26512477 0.75 RAB9A (0.34) MAPTKDM4EKDM4AGAAKMT2A
SCHEMBL7616338 0.75 DEPTOR (0.51) KDM4EKMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL26512342 0.72
SCHEMBL26512478 0.72 NPC1 (0.36) MAPTKDM4EKDM4AGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES UNIV COPENHAGEN (DK) 2023-10-12 US disclosed
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES UNIV COPENHAGEN (DK) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES GMPS, PDE11A, CGAS MAPT 375/4885KDM4E 3703/4885KDM4A 3275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.